Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibilityFAROOQI, J. Q; JABEEN, K; SAEED, N et al.Journal of medical microbiology. 2013, Vol 62, Num 2, pp 259-268, issn 0022-2615, 10 p.Article

Cryptococcus gattii in the United States: Clinical Aspects of Infection With an Emerging PathogenHARRIS, J. R; LOCKHART, S. R; DEBESS, E et al.Clinical infectious diseases. 2011, Vol 53, Num 12, pp 1188-1195, issn 1058-4838, 8 p.Article

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?ESPINEL-INGROFF, A; ARENDRUP, M. C; FULLER, J et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 12, pp 5836-5842, issn 0066-4804, 7 p.Article

Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and VoriconazoleESPINEL-INGROFF, A; ALLER, A. I; HAGEN, F et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 11, pp 5898-5906, issn 0066-4804, 9 p.Article

Cytoplasmic localization of the white phase-specific WH11 gene product of Candida albicansSCHRÖPPEL, K; SRIKANTHA, T; WESSELS, D et al.Microbiology (Reading). 1996, Vol 142, pp 2245-2254, issn 1350-0872, 8Article

Multilaboratory Study of Epidemiological Cutoff Values for Detection of Resistance in Eight Candida Species to Fluconazole, Posaconazole, and VoriconazoleESPINEL-INGROFF, A; PFALLER, M. A; MEIS, J. F et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 4, pp 2006-2012, issn 0066-4804, 7 p.Article

Development and use of complex probes for DNA fingerprinting the infectious fungiLOCKHART, S. R; PUJOL, C; JOLY, S et al.Medical mycology (Oxford. Print). 2001, Vol 39, Num 1, pp 1-8, issn 1369-3786Article

Candida albicans endocarditis associated with a contaminated aortic valve allograft : Implications for regulation of allograft processing. Author's replyKUEHNERT, M. J; CLARK, E; LOCKHART, S. R et al.Clinical infectious diseases. 1998, Vol 27, Num 4, pp 688-694, issn 1058-4838Conference Paper

Commitment of yeast pre-mRNA to the splicing pathway requires a novel U1 small nuclear ribonucleoprotein polypeptide, Prp39pLOCKHART, S. R; RYMOND, B. C.Molecular and cellular biology (Print). 1994, Vol 14, Num 6, pp 3623-3633, issn 0270-7306Article

Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution MethodPFALLER, M. A; ESPINEL-INGROFF, A; LOCKHART, S. R et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 2, pp 916-922, issn 0066-4804, 7 p.Article

Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3MARCO, F; LOCKHART, S. R; PATTERSON, J. E et al.Journal of clinical microbiology (Print). 1999, Vol 37, Num 9, pp 2817-2828, issn 0095-1137Article

Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolatesPFALLER, M. A; LOCKHART, S. R; PUJOL, C et al.Journal of clinical microbiology (Print). 1998, Vol 36, Num 6, pp 1518-1529, issn 0095-1137Article

Frequency, intensity, species, and strains of oral Candida vary as a function of host ageKLEINEGGER, C. L; LOCKHART, S. R; VARGAS, K et al.Journal of clinical microbiology (Print). 1996, Vol 34, Num 9, pp 2246-2254, issn 0095-1137Article

Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and FlucytosineESPINEL-LNGROFF, A; CHOWDHARY, A; LOCKHART, S. R et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 6, pp 3107-3113, issn 0066-4804, 7 p.Article

Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrataPFALLER, M. A; CASTANHEIRA, M; LOCKHART, S. R et al.Journal of clinical microbiology (Print). 2012, Vol 50, Num 4, pp 1199-1203, issn 0095-1137, 5 p.Article

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth MicrodilutionPFALLER, M. A; ESPINEL-INGROFF, A; LOCKHART, S. R et al.Journal of clinical microbiology (Print). 2012, Vol 50, Num 6, pp 2040-2046, issn 0095-1137, 7 p.Article

Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicansPUJOL, C; JOLY, S; LOCKHART, S. R et al.Journal of clinical microbiology (Print). 1997, Vol 35, Num 9, pp 2348-2358, issn 0095-1137Article

Development and verification of fingerprinting probes for Candida glabrataLOCKHART, S. R; JOLY, S; PUJOL, C et al.Microbiology (Reading). 1997, Vol 143, pp 3733-3746, issn 1350-0872, 12Article

Most frequent scenario for recurrent Candida vaginitis is strain maintenance with substrain shuffling : Demonstration by sequential DNA fingerprinting with probes Ca3, C1, and CARE2LOCKHART, S. R; REED, B. D; PIERSON, C. L et al.Journal of clinical microbiology (Print). 1996, Vol 34, Num 4, pp 767-777, issn 0095-1137Article

Colonizing populations of Candida albicans are clonal in origin but undergo microevolution through C1 fragment reorganization as demonstrated by DNA fingerprinting and C1 sequencingLOCKHART, S. R; FRITCH, J. J; STURDEVANT MEIER, A et al.Journal of clinical microbiology (Print). 1995, Vol 33, Num 6, pp 1501-1509, issn 0095-1137Article